Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues

Advanced Drug Delivery Reviews

Volumn 61, Issue 2, 2009, Pages 158-171

  Lai, Samuel K ^a   Wang, Ying Ying ^b   Hanes, Justin ^a,b,c  

^a Johns Hopkins University   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Mucus; Mucus barrier properties; Mucus penetrating particles; Therapeutic particles

Indexed keywords

ANATOMICAL LOCATIONS; DESIGN AND DEVELOPMENT; DRUG DELIVERY SYSTEMS; GENE DELIVERIES; LUNG AIRWAYS; MUCOSAL SURFACES; MUCOSAL TISSUES; MUCUS; MUCUS BARRIER PROPERTIES; MUCUS LAYERS; MUCUS-PENETRATING PARTICLES; SIDE EFFECTS; THERAPEUTIC PARTICLES; TRAPPED PARTICLES;

DRUG DELIVERY; DRUG INTERACTIONS; DRUG THERAPY; GELATION; GENE TRANSFER; HISTOLOGY; MACHINE DESIGN;

BODY FLUIDS;

MACROGOL; NANOPARTICLE;

BIOENGINEERING; DRUG DELIVERY SYSTEM; DRUG TRANSPORT; ELECTRON MICROSCOPY; GENE DELIVERY SYSTEM; HUMAN; HYDROPHOBICITY; MOLECULAR WEIGHT; MUCUS; MUCUS SECRETION; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; REVIEW; TRANSMISSION ELECTRON MICROSCOPY; VISCOELASTICITY;

ANIMALS; DRUG CARRIERS; GENE TRANSFER TECHNIQUES; HUMANS; MUCOUS MEMBRANE; MUCUS; NANOPARTICLES; VISCOSITY;

EID: 60149111908     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addr.2008.11.002     Document Type: Review

References (235)

1. Rosen H., and Abribat T. The rise and rise of drug delivery. Nat. Rev. Drug Discov. 4 (2005) 381-385
2. Shmulewitz A., Langer R., and Patton J. Convergence in biomedical technology. Nat. Biotechnol. 24 (2006) 277-280
3. Duncan R. The dawning era of polymer therapeutics. Nat. Rev. Drug Discov. 2 (2003) 347-360
4. Allen T.M., and Cullis P.R. Drug delivery systems: entering the mainstream. Science 303 (2004) 1818-1822
5. Langer R. Drug delivery and targeting. Nature 392 (1998) 5-10
6. Farokhzad O.C., and Langer R. Nanomedicine: Developing smarter therapeutic and diagnostic modalities. Adv. Drug Deliv. Rev. 58 (2006) 1456-1459
7. Prego C., Garcia M., Torres D., and Alonso M.J. Transmucosal macromolecular drug delivery. J. Control. Release 101 (2005) 151-162
8. Yuan F., Leunig M., Huang S.K., Berk D.A., Papahadjopoulos D., and Jain R.K. Mirovascular permeability and interstitial penetration of sterically stabilized (Stealth) liposomes in a human tumor xenograft. Cancer Res. 54 (1994) 3352-3356
9. MacKay J.A., Deen D.F., and Szoka J.F.C. Distribution in brain of liposomes after convection enhanced delivery; modulation by particle charge, particle diameter, and presence of steric coating. Brain Res. 1035 (2005) 139-153
10. Lai S.K., Hida K., Man S.T., Chen C., Machamer C., Schroer T.A., and Hanes J. Privileged delivery of polymer nanoparticles to the perinuclear region of live cells via a non-clathrin, non-degradative pathway. Biomaterials (2007)
11. Medina-Kauwe L.K., Xie J., and Hamm-Alvarez S. Intracellular trafficking of nonviral vectors. Gene Ther. 12 (2005) 1734-1751
12. Allemann E., Leroux J.-C., and Gurny R. Polymeric nano- and microparticles for the oral delivery of peptides and peptidomimetics. Adv. Drug Deliv. Rev. 34 (1998) 171-189
13. Panyam J., and Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv. Drug Deliv. Rev. 55 (2003) 329-347
14. Knowles M.R., and Boucher R.C. Mucus clearance as a primary innate defense mechanism for mammalian airways. J. Clin. Invest. 109 (2002) 571-577
15. Cone R. Mucus. In: Michael W.S., Lamm E., McGhee J.R., Mayer L., Mestecky J., and Bienenstock J. (Eds). Mucosal Immunlogy (1999), Academic Press, San Diego 43-64
16. Cone R. Barrier properties of mucus. Adv. Drug Deliv. Rev. 61 (2009) 75-85 10.1016/j.addr.2008.09.008
17. Lai S.K., O'Hanlon D.E., Harrold S., Man S.T., Wang Y.Y., Cone R., and Hanes J. Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 1482-1487
18. Braeckmans K., Peeters L., Sanders N.N., De Smedt S.C., and Demeester J. Three-dimensional fluorescence recovery after photobleaching with the confocal scanning laser microscope. Biophys. J. 85 (2003) 2240-2252
19. Olmsted S.S., Padgett J.L., Yudin A.I., Whaley K.J., Moench T.R., and Cone R.A. Diffusion of macromolecules and virus-like particles in human cervical mucus. Biophys. J. 81 (2001) 1930-1937
20. Arbos P., Campanero M.A., Arangoa M.A., Renedo M.J., and Irache J.M. Influence of the surface characteristics of PVM/MA nanoparticles on their bioadhesive properties. J. Control. Release 89 (2003) 19-30
21. Gruber P., Longer M.A., and Robinson J.R. Some biological issues in oral, controlled drug delivery. Adv. Drug Deliv. Rev. 1 (1987) 1-18
22. Lamprecht A., Schafer U., and Lehr C.M. Size-dependent bioadhesion of micro- and nanoparticulate carriers to the inflamed colonic mucosa. Pharm. Res. 18 (2001) 788-793
23. O'Mullane J.E., Artursson P., and Tomlinson E. Biopharmaceutics of microparticulate drug carriers. Ann. N. Y. Acad. Sci. 507 (1987) 120-140
24. Griesenbach U., and Alton E. Gene transfer to the lung: lessons learned from more than two decades of CF gene therapy. Adv. Drug Deliv. Rev. 61 (2009) 128-139 10.1016/j.addr.2008.09.010
25. Sanders N., Rudolph C., Braeckmans K., De Smedt S., and Demeester J. Extracellular barriers in respiratory gene therapy. Adv. Drug Deliv. Rev. 61 (2009) 115-127 10.1016/j.addr.2008.09.011
26. Carlstedt I., and Sheehan J.K. Structure and macromolecular properties of cervical mucus glycoproteins. Symp. Soc. Exp. Biol. 43 (1989) 289-316
27. Thornton D.J., and Sheehan J.K. From mucins to mucus: toward a more coherent understanding of this essential barrier. Proc. Am. Thorac. Soc. 1 (2004) 54-61
28. Wickstrom C., Davies J.R., Eriksen G.V., Veerman E.C., and Carlstedt I. MUC5B is a major gel-forming, oligomeric mucin from human salivary gland, respiratory tract and endocervix: identification of glycoforms and C-terminal cleavage. Biochem. J. 334 Pt 3 (1998) 685-693
29. Sheehan J.K., and Carlstedt I. Hydrodynamic properties of human cervical-mucus glycoproteins in 6M-guanidinium chloride. Biochem. J. 217 (1984) 93-101
30. Thornton D.J., Holmes D.F., Sheehan J.K., and Carlstedt I. Quantitation of mucus glycoproteins blotted onto nitrocellulose membranes. Anal. Biochem. 182 (1989) 160-164
31. Dekker J., Rossen J.W.A., Buller H.A., and Einerhand A.W.C. The MUC family: an obituary. Trends Biochem. Sci. 27 (2002) 126-131
32. Ali M.S., and Pearson J.P. Upper airway mucin gene expression: a review. Laryngoscope 117 (2007) 932-938
33. Rubin B.K. Physiology of airway mucus clearance. Respir. Care 47 (2002) 761-768
34. Corfield A.P., Carroll D., Myerscough N., and Probert C.S. Mucins in the gastrointestinal tract in health and disease. Front. Biosci. 6 (2001) D1321-1357
35. Gipson I.K. Mucins of the human endocervix. Front. Biosci. 6 (2001) D1245-1255
36. Thornton D.J., Carlstedt I., Howard M., Devine P.L., Price M.R., and Sheehan J.K. Respiratory mucins: identification of core proteins and glycoforms. Biochem. J. 316 Pt 3 (1996) 967-975
37. Van Klinken B.J., Dekker J., Buller H.A., and Einerhand A.W. Mucin gene structure and expression: protection vs. adhesion. Am. J. Physiol. 269 (1995) G613-G627
38. Slayter H.S., Wold J.K., and Midtvedt T. Intestinal mucin of germ-free rats. Biochemical and electron-microscopic characterization. Carbohydr. Res. 222 (1991) 1-9
39. Yurewicz E.C., Matsuura F., and Moghissi K.S. Structural studies of sialylated oligosaccharides of human midcycle cervical mucin. J. Biol. Chem. 262 (1987) 4733-4739
40. Allen A., Flemstrom G., Garner A., and Kivilaakso E. Gastroduodenal mucosal protection. Physiol. Rev. 73 (1993) 823-857
41. Carlstedt I., Lindgren H., Sheehan J.K., Ulmsten U., and Wingerup L. Isolation and characterization of human cervical-mucus glycoproteins. Biochem. J. 211 (1983) 13-22
42. Chao C.-C.W., Butala S.M., and Herp A. Studies on the isolation and composition of human ocular mucin. Exp. Eye Res. 47 (1988) 185-196
43. Quraishi M.S., Jones N.S., and Mason J. The rheology of nasal mucus: a review. Clin. Otolaryngol. 23 (1998) 403-413
44. Samet J.M., and Cheng P.W. The role of airway mucus in pulmonary toxicology. Environ. Health Perspect. 102 (1994) 89-103
45. Chao C.-C.W., Vergnes J.-P., and Brown S.I. Fractionation and partial characterization of macromolecular components from human ocular mucus. Exp. Eye Res. 36 (1983) 139-150
46. Engel E., Guth P.H., Nishizaki Y., and Kaunitz J.D. Barrier function of the gastric mucus gel. Am. J. Physiol.: Gasterointest. Liver Physiol. 269 (1995) G994-999
47. Lai S.K., Wang Y.Y., Wirtz D., and Hanes J. Micro- and macrorheology of mucus: implications for drug and gene delivery to mucosal tissues. Adv. Drug Deliv. Rev. 61 (2009) 86-100 10.1016/j.addr.2008.09.012
48. Wolf D.P., Blasco L., Khan M.A., and Litt M. Human cervical mucus. I. Rheologic characteristics. Fertil. Steril. 28 (1977) 41-46
49. Galabert C., Jacquot J., Zahm J.M., and Puchelle E. Relationships between the lipid content and the rheological properties of airway secretions in cystic fibrosis. Clin. Chim. Acta 164 (1987) 139-149
50. Girod S., Zahm J.M., Plotkowski C., Beck G., and Puchelle E. Role of the physiochemical properties of mucus in the protection of the respiratory epithelium. Eur. Respir. J. 5 (1992) 477-487
51. Raynal B.D., Hardingham T.E., Sheehan J.K., and Thornton D.J. Calcium-dependent protein interactions in MUC5B provide reversible cross-links in salivary mucus. J. Biol. Chem. 278 (2003) 28703-28710
52. Bhaskar K.R., Garik P., Turner B.S., Bradley J.D., Bansil R., Stanley H.E., and LaMont J.T. Viscous fingering of HCI through gastric mucin. Nature 360 (1992) 458-461
53. Celli J.P., Turner B.S., Afdhal N.H., Ewoldt R.H., McKinley G.H., Bansil R., and Erramilli S. Rheology of gastric mucin exhibits a pH-dependent sol-gel transition. Biomacromolecules 8 (2007) 1580-1586
54. Hehar S.S., Mason J.D., Stephen A.B., Washington N., Jones N.S., Jackson S.J., and Bush D. Twenty-four hour ambulatory nasal pH monitoring. Clin. Otolaryngol. Allied Sci. 24 (1999) 24-25
55. Jayaraman S., Joo N.S., Reitz B., Wine J.J., and Verkman A.S. Submucosal gland secretions in airways from cystic fibrosis patients have normal [Na(+)] and pH but elevated viscosity. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 8119-8123
56. Greaves J.L., and Wilson C.G. Treatment of diseases of the eye with mucoadhesive delivery systems. Adv. Drug Deliv. Rev. 11 (1993) 349-383
57. Schreiber S., and Scheid P. Gastric mucus of the guinea pig: proton carrier and diffusion barrier. Am. J. Physiol. 272 (1997) G63-70
58. Boskey E.R., Cone R.A., Whaley K.J., and Moench T.R. Origins of vaginal acidity: high D/L lactate ratio is consistent with bacteria being the primary source. Hum. Reprod. 16 (2001) 1809-1813
59. Valenta C. The use of mucoadhesive polymers in vaginal delivery. Adv. Drug Deliv. Rev. 57 (2005) 1692-1712
60. Sleigh M.A., Blake J.R., and Liron N. The propulsion of mucus by cilia. Am. Rev. Respir. Dis. 137 (1988) 726-741
61. Widdicombe J. Airway surface liquid: concepts and measurements. In: Lethem D.R.a.M. (Ed). Airway Mucus: Basic Mechanisms and Clinical Perspectives (1997), Birkhauser 1-18
62. Ally J., Ally J., Amirfazli A., and Roa W. Model studies of magnetic particle retention in the conducting airways. Proceedings of the 2005 International Conference on MEMS, NANO and Smart Systems (2005)
63. Overton J., and Miller F. Dosimetry modeling of inhaled toxic reactive gases. In: Watson R.B.A., and Kennedy D. (Eds). Air Pollution, the Automobile, and Public Health (1988), The National Academies Press
64. Clunes M.T., and Boucher R.C. Cystic fibrosis: the mechanisms of pathogenesis of an inherited lung disorder. Drug Discov. Today Dis. Mech. 4 (2007) 63-72
65. Matsui H., Grubb B.R., Tarran R., Randell S.H., Gatzy J.T., Davis C.W., and Boucher R.C. Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease. Cell 95 (1998) 1005-1015
66. Tarran R., Grubb B.R., Gatzy J.T., Davis C.W., and Boucher R.C. The relative roles of passive surface forces and active ion transport in the modulation of airway surface liquid volume and composition. J. Gen. Physiol. 118 (2001) 223-236
67. Verkman A.S., Song Y., and Thiagarajah J.R. Role of airway surface liquid and submucosal glands in cystic fibrosis lung disease. Am. J. Physiol., Cell Physiol. 284 (2003) C2-C15
68. Behrens I., Stenberg P., Artursson P., and Kissel T. Transport of lipophilic drug molecules in a new mucus-secreting cell culture model based on HT29-MTX cells. Pharm. Res. 18 (2001) 1138-1145
69. Copeman M., Matuz J., Leonard A.J., Pearson J.P., Dettmar P.W., and Allen A. The gastroduodenal mucus barrier and its role in protection against luminal pepsins: the effect of 16,16 dimethyl prostaglandin E2, carbopol-polyacrylate, sucralfate and bismuth subsalicylate. J. Gastroenterol. Hepatol. 9 Suppl 1 (1994) S55-59
70. Jordan N., Newton J., Pearson J., and Allen A. A novel method for the visualization of the in situ mucus layer in rat and man. Clin. Sci. 95 (1998) 97-106
71. Kerss S., Allen A., and Garner A. A simple method for measuring thickness of the mucus gel layer adherent to rat, frog and human gastric mucosa: influence of feeding, prostaglandin, N-acetylcysteine and other agents. Clin. Sci. 63 (1982) 187-195
72. Matsuo K., Ota H., Akamatsu T., Sugiyama A., and Katsuyama T. Histochemistry of the surface mucous gel layer of the human colon. Gut 40 (1997) 782-789
73. Pullan R.D., Thomas G.A., Rhodes M., Newcombe R.G., Williams G.T., Allen A., and Rhodes J. Thickness of adherent mucus gel on colonic mucosa in humans and its relevance to colitis. Gut 35 (1994) 353-359
74. van der Waaij L.A., Harmsen H.J., Madjipour M., Kroese F.G., Zwiers M., van Dullemen H.M., de Boer N.K., Welling G.W., and Jansen P.L. Bacterial population analysis of human colon and terminal ileum biopsies with 16S rRNA-based fluorescent probes: commensal bacteria live in suspension and have no direct contact with epithelial cells. Inflamm. Bowel Dis. 11 (2005) 865-871
75. Brownlee I.A., Havler M.E., Dettmar P.W., Allen A., and Pearson J.P. Colonic mucus: secretion and turnover in relation to dietary fibre intake. Proc. Nutr. Soc. 62 (2003) 245-249
76. Holly F.J., and Lemp M.A. Tear physiology and dry eyes. Surv. Ophthalmol. 22 (1977) 69-87
77. King-Smith P.E., Fink B.A., Hill R.M., Koelling K.W., and Tiffany J.M. The thickness of the tear film. Curr. Eye Res. 29 (2004) 357-368
78. Prydal J.I., Artal P., Woon H., and Campbell F.W. Study of human precorneal tear film thickness and structure using laser interferometry. Invest. Ophthalmol. Vis. Sci. 33 (1992) 2006-2011
79. Mainardes R.M., Urban M.C., Cinto P.O., Chaud M.V., Evangelista R.C., and Gremiao M.P. Liposomes and micro/nanoparticles as colloidal carriers for nasal drug delivery. Curr. Drug Deliv. 3 (2006) 275-285
80. Saketkhoo K., Januszkiewicz A., and Sackner M.A. Effects of drinking hot water, cold water, and chicken soup on nasal mucus velocity and nasal airflow resistance. Chest 74 (1978) 408-410
81. Galindo-Rodriguez S.A., Allemann E., Fessi H., and Doelker E. Polymeric nanoparticles for oral delivery of drugs and vaccines: a critical evaluation of in vivo studies. Crit. Rev. Ther. Drug Carr. Syst. 22 (2005) 419-464
82. Lehr C.M., Poelma F.G.J., Junginger H.E., and Tukker J.J. An estimate of turnover time of intestinal mucus gel layer in the rat in situ loop. Int. J. Pharm. 70 (1991) 235-240
83. Kieweg S.L., Geonnotti A.R., and Katz D.F. Gravity-induced coating flows of vaginal gel formulations: in vitro experimental analysis. J. Pharm. Sci. 93 (2004) 2941-2952
84. Kieweg S.L., and Katz D.F. Squeezing flows of vaginal gel formulations relevant to microbicide drug delivery. J. Biomech. Eng. 128 (2006) 540-553
85. Lamont J.T. Mucus: the front line of intestinal mucosal defense. Ann. N. Y. Acad. Sci. 664 (1992) 190-201
86. Saltzman W.M., Radomsky M.L., Whaley K.J., and Cone R.A. Antibody diffusion in human cervical-mucus. Biophys. J. 66 (1994) 508-515
87. Amsden B. Solute diffusion within hydrogels. Mechanisms and models. Macromolecules 31 (1998) 8382-8395
88. Amsden B. An obstruction-scaling model for diffusion in homogeneous hydrogels. Macromolecules 32 (1999) 874-879
89. Hanes J., Dawson M., Har-el Y., Suh J., and Fiegel J. Gene delivery to the lung. In: Hickey A.J. (Ed). Pharmaceutical Inhalation Aerosol Technology (2003), Marcel Dekker Inc., New York 489-539
90. Norris D.A., and Sinko P.J. Effect of size, surface charge, and hydrophobicity on the translocation of polystyrene microspheres through gastrointestinal mucin. J. Appl. Polym. Sci. 63 (1997) 1481-1492
91. Sheehan J.K., Oates K., and Carlstedt I. Electron microscopy of cervical, gastric and bronchial mucus glycoproteins. Biochem. J. 239 (1986) 147-153
92. Drumm B., Neumann A.W., Policova Z., and Sherman P.M. Bacterial cell surface hydrophobicity properties in the mediation of in vitro adhesion by the rabbit enteric pathogen Escherichia coli strain RDEC-1. J. Clin. Invest. 84 (1989) 1588-1594
93. Sajjan U., Reisman J., Doig P., Irvin R.T., Forstner G., and Forstner J. Binding of nonmucoid Pseudomonas aeruginosa to normal human intestinal mucin and respiratory mucin from patients with cystic fibrosis. J. Clin. Invest. 89 (1992) 657-665
94. Mantle M., Basaraba L., Peacock S.C., and Gall D.G. Binding of Yersinia enterocolitica to rabbit intestinal brush border membranes, mucus, and mucin. Infect. Immun. 57 (1989) 3292-3299
95. Bala I., Hariharan S., and Kumar M.N. PLGA nanoparticles in drug delivery: the state of the art. Crit. Rev. Ther. Drug Carr. Syst. 21 (2004) 387-422
96. Kumar N., Langer R.S., and Domb A.J. Polyanhydrides: an overview. Adv. Drug Deliv. Rev. 54 (2002) 889-910
97. Pack D.W., Hoffman A.S., Pun S., and Stayton P.S. Design and development of polymers for gene delivery. Nat. Rev. Drug Discov. 4 (2005) 581-593
98. Kircheis R.L.W., and Wagner E. Design and gene delivery activity of modified polyethylenimines. Adv. Drug Deliv. Rev. 53 (2001) 341-358
99. Durrer C., Irache J.M., Puisieux F., Duchene D., and Ponchel G. Mucoadhesion of latexes. II. Adsorption isotherms and desorption studies. Pharm. Res. 11 (1994) 680-683
100. Durrer C., Irache J.M., Puisieux F., Duchene D., and Ponchel G. Mucoadhesion of latexes. I. Analytical methods and kinetic studies. Pharm. Res. 11 (1994) 674-679
101. Ponchel G., Montisci M.-J., Dembri A., Durrer C., and Duchene D. Mucoadhesion of colloidal particulate systems in the gastro-intestinal tract. Eur. J. Pharm. Biopharm. 44 (1997) 25-31
102. Larhed A.W., Artursson P., Grasjo J., and Bjork E. Diffusion of drugs in native and purified gastrointestinal mucus. J. Pharm. Sci. 86 (1997) 660-665
103. Matthes I., Nimmerfall F., Vonderscher J., and Sucker H. [Mucus models for investigation of intestinal absorption mechanisms. 4. Comparison of mucus models with absorption models in vivo and in situ for prediction of intestinal drug absorption]. Pharmazie 47 (1992) 787-791
104. Khanvilkar K., Donovan M.D., and Flanagan D.R. Drug transfer through mucus. Adv. Drug Deliv. Rev. 48 (2001) 173-193
105. Saitoh H., Hasegawa N., Kawai S., Miyazaki K., and Arita T. Interaction of tertiary amines and quaternary ammonium compounds with gastrointestinal mucin. J. Pharm. 9 (1986) 1008-1014
106. Desai M.A., Mutlu M., and Vadgama P. A study of macromolecular diffusion through native porcine mucus. Experientia 48 (1992) 22-26
107. Bhat P.G., Flanagan D.R., and Donovan M.D. The limiting role of mucus in drug absorption: Drug permeation through mucus solution. Int. J. Pharm. 126 (1995) 179-187
108. Bhat P.G., Flanagan D.R., and Donovan M.D. Drug diffusion through cystic fibrotic mucus: steady-state permeation, rheologic properties, and glycoprotein morphology. J. Pharm. Sci. 85 (1996) 624-630
109. Ponchel G., and Irache J. Specific and non-specific bioadhesive particulate systems for oral delivery to the gastrointestinal tract. Adv. Drug Deliv. Rev. 34 (1998) 191-219
110. Kreuter J., Muller U., and Munz K. Quantitative and microautoradiographic study on mouse intestinal distribution of polycyanoacrylate nanoparticles. Int. J. Pharm. 55 (1989) 39-45
111. Woodley J. Bioadhesion: new possibilities for drug administration?. Clin. Pharmacokinet. 40 (2001) 77-84
112. Sanders N.N., De Smedt S.C., Van Rompaey E., Simoens P., De Baets F., and Demeester J. Cystic fibrosis sputum: a barrier to the transport of nanospheres. Am. J. Respir. Crit. Care Med. 162 (2000) 1905-1911
113. Broughton-Head V.J., Smith J.R., Shur J., and Shute J.K. Actin limits enhancement of nanoparticle diffusion through cystic fibrosis sputum by mucolytics. Pulm. Pharmacol. Ther. (2006)
114. Shen H., Hu Y., and Saltzman W.M. DNA diffusion in mucus: effect of size, topology of DNAs, and transfection reagents. Biophys. J. 91 (2006) 639-644
115. Suh J., Dawson M., and Hanes J. Real-time multiple-particle tracking: applications to drug and gene delivery. Adv. Drug Deliv. Rev. 57 (2005) 63-78
116. Suh J., Wirtz D., and Hanes J. Efficient active transport of gene nanocarriers to the cell nucleus. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 3878-3882
117. Suk J.S., Suh J., Lai S.K., and Hanes J. Quantifying the intracellular transport of viral and nonviral gene vectors in primary neurons. Exp. Biol. Med. 232 (2007) 461-469
118. Dawson M., Wirtz D., and Hanes J. Enhanced viscoelasticity of human cystic fibrotic sputum correlates with increasing microheterogeneity in particle transport. J. Biol. Chem. 278 (2003) 50393-50401
119. Dawson M., Krauland E., Wirtz D., and Hanes J. Transport of polymeric nanoparticle gene carriers in gastric mucus. Biotechnol. Prog. 20 (2004) 851-857
120. Lai S.K., Hida K., Chen C., and Hanes J. Characterization of the intracellular dynamics of a non-degradative pathway accessed by polymer nanoparticles. J. Control. Release 125 (2008) 107-111
121. Florence A.T. The oral absorption of micro- and nanoparticulates: neither exceptional nor unusual. Pharm. Res. 14 (1997) 259-266
122. Florey H.W. The secretion and function of intestinal mucus. Gastroenterology 43 (1962) 326-329
123. Tirosh B., and Rubinstein A. Migration of adhesive and nonadhesive particles in the rat intestine under altered mucus secretion conditions. J. Pharm. Sci. 87 (1998) 453-456
124. Bernkop-Schnurch A. Thiomers: a new generation of mucoadhesive polymers. Adv. Drug Deliv. Rev. 57 (2005) 1569-1582
125. Prego C., Torres D., and Alonso M.J. The potential of chitosan for the oral administration of peptides. Expert Opin. Drug Deliv. 2 (2005) 843-854
126. Jubeh T.T., Barenholz Y., and Rubinstein A. Differential adhesion of normal and inflamed rat colonic mucosa by charged liposomes. Pharm. Res. 21 (2004) 447-453
127. Lele B.S., and Hoffman A.S. Mucoadhesive drug carriers based on complexes of poly(acrylic acid) and PEGylated drugs having hydrolysable PEG-anhydride-drug linkages. J. Control. Release 69 (2000) 237-248
128. Peppas N.A., Keys K.B., Torres-Lugo M., and Lowman A.M. Poly(ethylene glycol)-containing hydrogels in drug delivery. J. Control. Release 62 (1999) 81-87
129. Yoncheva K., Gomez S., Campanero M.A., Gamazo C., and Irache J.M. Bioadhesive properties of pegylated nanoparticles. Expert Opin. Drug Deliv. 2 (2005) 205-218
130. Takeuchi H., Yamamoto H., and Kawashima Y. Mucoadhesive nanoparticulate systems for peptide drug delivery. Adv. Drug Deliv. Rev. 47 (2001) 39-54
131. Keely S., Rullay A., Wilson C., Carmichael A., Carrington S., Corfield A., Haddleton D.M., and Brayden D.J. In vitro and ex vivo intestinal tissue models to measure mucoadhesion of poly (methacrylate) and N-trimethylated chitosan polymers. Pharm. Res. 22 (2005) 38-49
132. Quintanar-Guerrero D., Villalobos-Garcia R., Alvarez-Colin E., and Cornejo-Bravo J.M. In vitro evaluation of the bioadhesive properties of hydrophobic polybasic gels containing N,N-dimethylaminoethyl methacrylate-co-methyl methacrylate. Biomaterials 22 (2001) 957-961
133. Chickering D., Jacob J., and Mathiowitz E. Poly(fumaric-co-sebacic) microspheres as oral drug delivery systems. Biotechnol. Bioeng. 52 (1996) 96-101
134. Mathiowitz E., Jacob J.S., Jong Y.S., Carino G.P., Chickering D.E., Chaturvedi P., Santos C.A., Vijayaraghavan K., Montgomery S., Bassett M., and Morrell C. Biologically erodable microsphere as potential oral drug delivery system. Nature 386 (1997) 410-414
135. Naisbett B., and Woodley J. The potential use of tomato lectin for oral-drug delivery .3. Bioadhesion in-vivo. Int. J. Pharm. 114 (1995) 227-236
136. Lehr C.M., Bouwstra J.A., Kok W., Noach A.B., de Boer A.G., and Junginger H.E. Bioadhesion by means of specific binding of tomato lectin. Pharm. Res. 9 (1992) 547-553
137. Irache J.M., Durrer C., Duchene D., and Ponchel G. Bioadhesion of lectin-latex conjugates to rat intestinal mucosa. Pharm. Res. 13 (1996) 1716-1719
138. Montisci M.J., Dembri A., Giovannuci G., Chacun H., Duchene D., and Ponchel G. Gastrointestinal transit and mucoadhesion of colloidal suspensions of Lycopersicon esculentum L. and Lotus tetragonolobus lectin-PLA microsphere conjugates in rats. Pharm. Res. 18 (2001) 829-837
139. Haltner E., Easson J.H., Russel-Jones G., and Lehr C.M. A rapid assay for bioadhesion of lectin-functionalized nano-particles to Caco-2 cell monolayers. J. Control. Release 41 (1996) S3
140. Irache J.M., Durrer C., Duchene D., and Ponchel G. Preparation and characterization of lectin-latex conjugates for specific bioadhesion. Biomaterials 15 (1994) 899-904
141. Janes K.A., Calvo P., and Alonso M.J. Polysaccharide colloidal particles as delivery systems for macromolecules. Adv. Drug Deliv. Rev. 47 (2001) 83-97
142. Fernandez-Urrusuno R., Calvo P., Remunan-Lopez C., Vila-Jato J.L., and Alonso M.J. Enhancement of nasal absorption of insulin using chitosan nanoparticles. Pharm. Res. 16 (1999) 1576-1581
143. Pan Y., Li Y.J., Zhao H.Y., Zheng J.M., Xu H., Wei G., Hao J.S., and Cui F.D. Bioadhesive polysaccharide in protein delivery system: chitosan nanoparticles improve the intestinal absorption of insulin in vivo. Int. J. Pharm. 249 (2002) 139-147
144. Prego C., Torres D., and Alonso M.J. Chitosan nanocapsules as carriers for oral peptide delivery: effect of chitosan molecular weight and type of salt on the in vitro behaviour and in vivo effectiveness. J. Nanosci. Nanotechnol. 6 (2006) 2921-2928
145. Roy K., Mao H.Q., Huang S.K., and Leong K.W. Oral gene delivery with chitosan-DNA nanoparticles generates immunologic protection in a murine model of peanut allergy. Nat. Med. 5 (1999) 387-391
146. Damge C., Vranckx H., Balschmidt P., and Couvreur P. Poly(alkyl cyanoacrylate) nanospheres for oral administration of insulin. J. Pharm. Sci. 86 (1997) 1403-1409
147. Lowe P.J., and Temple C.S. Calcitonin and insulin in isobutylcyanoacrylate nanocapsules: protection against proteases and effect on intestinal absorption in rats. J. Pharm. Pharmacol. 46 (1994) 547-552
148. Sarmento B., Ribeiro A., Veiga F., Sampaio P., Neufeld R., and Ferreira D. Alginate/chitosan nanoparticles are effective for oral insulin delivery. Pharm. Res. 24 (2007) 2198-2206
149. Neutra M.R., and Forstner J.F. Gastrointestinal mucus: synthesis, secretion and function. In: Johnson L.R. (Ed). Physiology of the Gastrointestinal Tract (1987), Raven, New York 975-1009
150. Lavelle E.C., Sharif S., Thomas N.W., Holland J., and Davis S.S. The importance of gastrointestinal uptake of particles in the design of oral delivery systems. Adv. Drug Deliv. Rev. 18 (1995) 5-22
151. Jani P.U., Mccarthy D.E., and Florence A.T. Nanosphere and microsphere uptake via Peyer patches - observation of the rate of uptake in the rat after a single oral dose. Int. J. Pharm. 86 (1992) 239-246
152. Jani P.U., Halbert G.W., Langridge J., and Florence A.T. The uptake and translocation of latex nanospheres and microspheres after oral administration to rats. J. Pharm. Pharmacol. 41 (1989) 809-812
153. Scherer D., Mooren F.C., Kinne R.K., and Kreuter J. In vitro permeability of PBCA nanoparticles through porcine small intestine. J. Drug Target. 1 (1993) 21-27
154. O'Hagan D.T. The intestinal uptake of particles and the implications for drug and antigen delivery. J. Anat. 189 Pt 3 (1996) 477-482
155. Sternson L.A. Obstacles to polypeptide delivery. Ann. N. Y. Acad. Sci. 507 (1987) 19-21
156. des Rieux A., Fievez V., Garinot M., Schneider Y.-J., and Preat V. Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach. J. Control. Release 116 (2006) 1-27
157. Florence A.T., Sakthivel T., and Toth I. Oral uptake and translocation of a polylysine dendrimer with a lipid surface. J. Control. Release 65 (2000) 253-259
158. Hillyer J.F., and Albrecht R.M. Gastrointestinal persorption and tissue distribution of differently sized colloidal gold nanoparticles. J. Pharm. Sci. 90 (2001) 1927-1936
159. Delie F. Evaluation of nano- and microparticle uptake by the gastrointestinal tract. Adv. Drug Deliv. Rev. 34 (1998) 221-233
160. Clark M.A., Jepson M.A., and Hirst B.H. Exploiting M cells for drug and vaccine delivery. Adv. Drug Deliv. Rev. 50 (2001) 81-106
161. Czerkinsky C., Svennerholm A.M., and Holmgren J. Induction and assessment of immunity at enteromucosal surfaces in humans: implications for vaccine development. Clin. Infect. Dis. 16 Suppl. 2 (1993) S106-S116
162. Langer R., Cleland J.L., and Hanes J. New advances in microsphere-based single-dose vaccines. Adv. Drug Deliv. Rev. 28 (1997) 97-119
163. Challacombe S.J., Rahman D., Jeffery H., Davis S.S., and O'Hagan D.T. Enhanced secretory IgA and systemic IgG antibody responses after oral immunization with biodegradable microparticles containing antigen. Immunology 76 (1992) 164-168
164. O'Hagan D.T., McGee J.P., Holmgren J., Mowat A.M., Donachie A.M., Mills K.H., Gaisford W., Rahman D., and Challacombe S.J. Biodegradable microparticles for oral immunization. Vaccine 11 (1993) 149-154
165. Eldridge J.H., Hammond C.J., Meulbroek J.A., Staas J.K., Gilley R.M., and Tice T.R. Controlled vaccine release in the gut-associated lymphoid-tissues .1. Orally-administered biodegradable microspheres target the Peyers patches. J. Control. Release 11 (1990) 205-214
166. Jung T., Kamm W., Breitenbach A., Hungerer K.D., Hundt E., and Kissel T. Tetanus toxoid loaded nanoparticles from sulfobutylated poly(vinyl alcohol)-graft-poly(lactide-co-glycolide): evaluation of antibody response after oral and nasal application in mice. Pharm. Res. 18 (2001) 352-360
167. Bhavsar M.D., and Amiji M.M. Polymeric nano- and microparticle technologies for oral gene delivery. Expert Opin. Drug Deliv. 4 (2007) 197-213
168. Bernkop-Schnurch A. Mucoadhesive systems in oral drug delivery. Drug Discov. Today: Technol. 2 (2005) 83-87
169. Wada A., and Nakamura H. Nature of the charge distribution in proteins. Nature 293 (1981) 757-758
170. Sakuma S., Sudo R., Suzuki N., Kikuchi H., Akashi M., and Hayashi M. Mucoadhesion of polystyrene nanoparticles having surface hydrophilic polymeric chains in the gastrointestinal tract. Int. J. Pharm. 177 (1999) 161-172
171. Sakuma S., Sudo R., Suzuki N., Kikuchi H., Akashi M., Ishida Y., and Hayashi M. Behavior of mucoadhesive nanoparticles having hydrophilic polymeric chains in the intestine. J. Control. Release 81 (2002) 281-290
172. Ai H., Jones S.A., and Lvov Y.M. Biomedical applications of electrostatic layer-by-layer nano-assembly of polymers, enzymes, and nanoparticles. Cell Biochem. Biophys. 39 (2003) 23-43
173. Bertrand P., Jonas A., Laschewsky A., and Legras R. Ultrathin polymer coatings by complexation of polyelectrolytes at interfaces: suitable materials, structure and properties. Macromol. Rapid Commun. 21 (2000) 319-348
174. Harris J.M., and Chess R.B. Effect of pegylation on pharmaceuticals. Nat. Rev. Drug Discov. 2 (2003) 214-221
175. Huang Y., Leobandung W., Foss A., and Peppas N.A. Molecular aspects of muco- and bioadhesion: tethered structures and site-specific surfaces. J. Control. Release 65 (2000) 63-71
176. Bures P., Huang Y., Oral E., and Peppas N.A. Surface modifications and molecular imprinting of polymers in medical and pharmaceutical applications. J. Control. Release 72 (2001) 25-33
177. Fresta M., Fontana G., Bucolo C., Cavallaro G., Giammona G., and Puglisi G. Ocular tolerability and in vivo bioavailability of poly(ethylene glycol) (PEG)-coated polyethyl-2-cyanoacrylate nanosphere-encapsulated acyclovir. J. Pharm. Sci. 90 (2001) 288-297
178. Serra L., Domenech J., and Peppas N.A. Design of poly(ethylene glycol)-tethered copolymers as novel mucoadhesive drug delivery systems. Eur. J. Pharm. Biopharm. 63 (2006) 11-18
179. Sahlin J.J., and Peppas N.A. Enhanced hydrogel adhesion by polymer interdiffusion: use of linear poly(ethylene glycol) as an adhesion promoter. J. Biomater. Sci., Polym. Ed. 8 (1997) 421-436
180. Giannavola C., Bucolo C., Maltese A., Paolino D., Vandelli M.A., Puglisi G., Lee V.H., and Fresta M. Influence of preparation conditions on acyclovir-loaded poly-d,l-lactic acid nanospheres and effect of PEG coating on ocular drug bioavailability. Pharm. Res. 20 (2003) 584-590
181. Sezgin Z., Yuksel N., and Baykara T. Investigation of pluronic and PEG-PE micelles as carriers of meso-tetraphenyl porphine for oral administration. Int. J. Pharm. 332 (2007) 161-167
182. Yoncheva K., Guembe L., Campanero M.A., and Irache J.M. Evaluation of bioadhesive potential and intestinal transport of pegylated poly(anhydride) nanoparticles. Int. J. Pharm. 334 (2007) 156-165
183. Wang Y.Y., Lai S.K., Suk J.S., Pace A., Cone R., and Hanes J. Addressing the PEG mucoadhesivity paradox to engineer nanoparticles that "slip" through the human mucus barrier. Angew. Chem., Int. Ed. Engl. (2008) 9726-9729
184. Chia-Ming C., and Weiner N. Gastrointestinal uptake of liposomes. I. In vitro and in situ studies. Int. J. Pharm. 37 (1987) 75-85
185. Rowland R.N., and Woodley J.F. The stability of liposomes in vitro to pH, bile salts and pancreatic lipase. Biochim. Biophys. Acta 620 (1980) 400-409
186. Sanders N.N., Van Rompaey E., De Smedt S.C., and Demeester J. Structural alterations of gene complexes by cystic fibrosis sputum. Am. J. Respir. Crit. Care Med. 164 (2001) 486-493
187. Sanders N.N., De Smedt S.C., and Demeester J. Mobility and stability of gene complexes in biogels. J. Control. Release 87 (2003) 117-129
188. Sanders N.N., De Smedt S.C., Cheng S.H., and Demeester J. Pegylated GL67 lipoplexes retain their gene transfection activity after exposure to components of CF mucus. Gene Ther. 9 (2002) 363-371
189. Kim D.H., and Martin D.C. Sustained release of dexamethasone from hydrophilic matrices using PLGA nanoparticles for neural drug delivery. Biomaterials 27 (2006) 3031-3037
190. Yoo H.S., Oh J.E., Lee K.H., and Park T.G. Biodegradable nanoparticles containing doxorubicin-PLGA conjugate for sustained release. Pharm. Res. 16 (1999) 1114-1118
191. Fu K., Harrell R., Zinski K., Um C., Jaklenec A., Frazier J., Lotan N., Burke P., Klibanov A.M., and Langer R. A potential approach for decreasing the burst effect of protein from PLGA microspheres. J. Pharm. Sci. 92 (2003) 1582-1591
192. Gref R., Minamitake Y., Peracchia M.T., Trubetskoy V., Torchilin V., and Langer R. Biodegradable long-circulating polymeric nanospheres. Science 263 (1994) 1600-1603
193. Rejman J., Oberle V., Zuhorn I.S., and Hoekstra D. Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis. Biochem. J. 377 (2004) 159-169
194. Rubin B.K. Mucus structure and properties in cystic fibrosis. Paediatr. Respir. Rev. 8 (2007) 4-7
195. Boucher R.C. An overview of the pathogenesis of cystic fibrosis lung disease. Adv. Drug Deliv. Rev. 54 (2002) 1359-1371
196. Summary Conclusion of the 17th Annual North American Cystic Fibrosis Conference. Anaheim, California, USA. October 16-19, 2003. Pediatr Pulmonol Suppl vol. 25 (2003) 92-394
197. Kitson C., Angel B., Judd D., Rothery S., Severs N.J., Dewar A., Huang L., Wadsworth S.C., Cheng S.H., Geddes D.M., and Alton E.W. The extra- and intracellular barriers to lipid and adenovirus-mediated pulmonary gene transfer in native sheep airway epithelium. Gene Ther. 6 (1999) 534-546
198. Shak S., Capon D.J., Hellmiss R., Marsters S.A., and Baker C.L. Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum. Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 9188-9192
199. Shah P.L., Scott S.F., Knight R.A., Marriott C., Ranasinha C., and Hodson M.E. In vivo effects of recombinant human DNase I on sputum in patients with cystic fibrosis. Thorax 51 (1996) 119-125
200. Sheffner A.L., Medler E.M., Jacobs L.W., and Sarett H.P. The in vitro reduction in viscosity of human tracheobronchial secretions by acetylcysteine. Am. Rev. Respir. Dis. 90 (1964) 721-729
201. Henke M.O., and Ratjen F. Mucolytics in cystic fibrosis. Paediatr. Respir. Rev. 8 (2007) 24-29
202. Ferrari S., Kitson C., Farley R., Steel R., Marriott C., Parkins D.A., Scarpa M., Wainwright B., Evans M.J., Colledge W.H., Geddes D.M., and Alton E.W. Mucus altering agents as adjuncts for nonviral gene transfer to airway epithelium. Gene Ther. 8 (2001) 1380-1386
203. App E.M., Baran D., Dab I., Malfroot A., Coffiner M., Vanderbist F., and King M. Dose-finding and 24-h monitoring for efficacy and safety of aerosolized Nacystelyn in cystic fibrosis. Eur. Respir. J. 19 (2002) 294-302
204. Tomkiewicz R.P., App E.M., De Sanctis G.T., Coffiner M., Maes P., Rubin B.K., and King M. A comparison of a new mucolytic N-acetylcysteine L-lysinate with N-acetylcysteine: airway epithelial function and mucus changes in dog. Pulm. Pharmacol. 8 (1995) 259-265
205. Vasconcellos C.A., Allen P.G., Wohl M.E., Drazen J.M., Janmey P.A., and Stossel T.P. Reduction in viscosity of cystic fibrosis sputum in vitro by gelsolin. Science 263 (1994) 969-971
206. Rubin B.K., Kater A.P., and Goldstein A.L. Thymosin beta4 sequesters actin in cystic fibrosis sputum and decreases sputum cohesivity in vitro. Chest 130 (2006) 1433-1440
207. Sanders N.N., Franckx H., De Boeck K., Haustraete J., De Smedt S.C., and Demeester J. Role of magnesium in the failure of rhDNase therapy in patients with cystic fibrosis. Thorax 61 (2006) 962-968
208. Jordan N., Newton J., Pearson J., and Allen A. A novel method for the visualization of the in situ mucus layer in rat and man. Clin. Sci. (Lond) 95 (1998) 97-106
209. Kerss S., Allen A., and Garner A. A simple method for measuring thickness of the mucus gel layer adherent to rat, frog and human gastric mucosa: influence of feeding, prostaglandin, N-acetylcysteine and other agents. Clin. Sci. (Lond) 63 (1982) 187-195
210. Atuma C., Strugala V., Allen A., and Holm L. The adherent gastrointestinal mucus gel layer: thickness and physical state in vivo. Am. J. Physiol.: Gasterointest. Liver Physiol. 280 (2001) G922-929
211. Strugala V., Allen A., Dettmar P.W., and Pearson J.P. Colonic mucin: methods of measuring mucus thickness. Proc. Nutr. Soc. 62 (2003) 237-243
212. Szentkuti L., and Lorenz K. The thickness of the mucus layer in different segments of the rat intestine. Histochem. J. 27 (1995) 466-472
213. Schuhl J.F. Nasal mucociliary clearance in perennial rhinitis. J. Investig. Allergol. Clin. Immunol. 5 (1995) 333-336
214. Illum L. Nasal drug delivery-possibilities, problems and solutions. J. Control. Release 87 (2003) 187-198
215. Mitra A.K., and Krishnamoorthy R. Prodrugs for nasal drug delivery. Adv. Drug Deliv. Rev. 29 (1998) 135-146
216. Wong J.W., Keens T.G., Wannamaker E.M., Crozier D.N., Levison H., and Aspin N. Effects of gravity on tracheal mucus transport rates in normal subjects and in patients with cystic fibrosis. Pediatrics 60 (1977) 146-152
217. Foster W.M., Langenback E., and Bergofsky E.H. Measurement of tracheal and bronchial mucus velocities in man: relation to lung clearance. J. Appl. Physiol. 48 (1980) 965-971
218. Hofmann W., and Asgharian B. The effect of lung structure on mucociliary clearance and particle retention in human and rat lungs. Toxicol. Sci. 73 (2003) 448-456
219. Leikauf G., Yeates D.B., Wales K.A., Spektor D., Albert R.E., and Lippmann M. Effects of sulfuric acid aerosol on respiratory mechanics and mucociliary particle clearance in healthy nonsmoking adults. Am. Ind. Hyg. Assoc. J. 42 (1981) 273-282
220. Yeates D.B., Aspin N., Levison H., Jones M.T., and Bryan A.C. Mucociliary tracheal transport rates in man. J. Appl. Physiol. 39 (1975) 487-495
221. Yeates D.B., Gerrity T.R., and Garrard C.S. Characteristics of tracheobronchial deposition and clearance in man. Ann. Occup. Hyg. 26 (1982) 245-257
222. Yeates D.B., Pitt B.R., Spektor D.M., Karron G.A., and Albert R.E. Coordination of mucociliary transport in human trachea and intrapulmonary airways. J. Appl. Physiol. 51 (1981) 1057-1064
223. Denton R. The rheology of human lung mucus. Ann. N. Y. Acad. Sci. 106 (1963) 746-754
224. Friedman M., Dougherty R., Nelson S.R., White R.P., Sackner M.A., and Wanner A. Acute effects of an aerosol hair spray on tracheal mucociliary transport. Am. Rev. Respir. Dis. 116 (1977) 281-286
225. Goodman R.M., Yergin B.M., Landa J.F., Golivanux M.H., and Sackner M.A. Relationship of smoking history and pulmonary function tests to tracheal mucous velocity in nonsmokers, young smokers, ex-smokers, and patients with chronic bronchitis. Am. Rev. Respir. Dis. 117 (1978) 205-214
226. Sackner M.A., Landa J., Hirsch J., and Zapata A. Pulmonary effects of oxygen breathing. A 6-hour study in normal men. Ann. Intern. Med. 82 (1975) 40-43
227. Santa Cruz R., Landa J., Hirsch J., and Sackner M.A. Tracheal mucous velocity in normal man and patients with obstructive lung disease: effects of terbutaline. Am. Rev. Respir. Dis. 109 (1974) 458-463
228. Toomes H., Vogt-Moykopf I., Heller W.D., and Ostertag H. Measurement of mucociliary clearance in smokers and nonsmokers using a bronchoscopic video-technical method. Lung 159 (1981) 27-34
229. Wanner A., Salathe M., and O'Riordan T.G. Mucociliary clearance in the airways. Am. J. Respir. Crit. Care Med. 154 (1996) 1868-1902
230. Yeates D.B., Gerrity T.R., and Garrard C.S. Particle deposition and clearance in the bronchial tree. Ann. Biomed. Eng. 9 (1981) 577-592
231. Donaldson S.H., Corcoran T.E., Laube B.L., and Bennett W.D. Mucociliary clearance as an outcome measure for cystic fibrosis clinical research. Proc. Am. Thorac. Soc. 4 (2007) 399-405
232. Yoncheva K., Guembe L., Campanero M.A., and Irache J.M. Evaluation of bioadhesive potential and intestinal transport of pegylated poly(anhydride) nanoparticles. Int. J. Pharm. 334 (2007) 156-165
233. Yoncheva K., Lizarraga E., and Irache J.M. Pegylated nanoparticles based on poly(methyl vinyl ether-co-maleic anhydride): preparation and evaluation of their bioadhesive properties. Eur. J. Pharm. Sci. 24 (2005) 411-419
234. Behrens I., Pena A.I., Alonso M.J., and Kissel T. Comparative uptake studies of bioadhesive and non-bioadhesive nanoparticles in human intestinal cell lines and rats: the effect of mucus on particle adsorption and transport. Pharm. Res. 19 (2002) 1185-1193
235. Fresta M., Fontana G., Bucolo C., Cavallaro G., Giammona G., and Puglisi G. Ocular tolerability and in vivo bioavailability of poly(ethylene glycol) (PEG)-coated polyethyl-2-cyanoacrylate nanosphere-encapsulated acyclovir. J. Pharm. Sci. 90 (2001) 288-297